Expert says lessons should be learned from breast implant crisis

January 13, 2012

The social, and psychological reasons women have breast implant surgery are complex and multi-faceted says Professor Julie Kent a sociologist from the Center for Health & Clinical Research at UWE Bristol. These considerations, as well as ethical issues, need to be part of the debate on faulty breast implants, in order for lessons to be learned from the current crisis says Professor Kent.

Professor Kent is an expert in the ethics and policy issues relating to health technologies and she has carried out extensive research into the politics of breast implants.

Professor Kent says, “We live in a society where appearance matters a great deal and the social pressures to look good, to conform to notions of a 'normal body' create demand for implant technologies to restore or enhance bodily form.”

“What kinds of risks are women willing to take with their health? Breast implants of all kinds are known to have a limited life and are likely to need replacement. Surgery in itself is a risky procedure.”

“Women need support and information which enables them to make informed decisions about the risks breast implants can pose to health whether they contain defective filler materials or not, while anyone who deliberately flouts safety standards in manufacturing healthcare products should expect to face the rule of criminal law.”

Despite the current crisis, Professor Kent says safety concerns about breast implants are not a new issue. There have been debates in the past about whether commercial interests exploit women who seek breast implantation and whether regulation of the cosmetic surgery industry is adequate.

Professor Kent continues, “Successive UK inquiries and government reports have concluded that a duty of care towards those who seek cosmetic surgery should be a key ethical principle. However, it remains to be seen whether this will lead to private clinics providing appropriate support to women in the current crisis.”

“While the risks to women's health and concerns about safety are being taken very seriously by the regulatory agency MHRA and the Department of Health, the absence of reliable data on which to formulate policy is a longstanding problem.

“Funding was withdrawn from the UK National Breast Implant Registry and it was closed in 2007 because the data was considered inadequate and unable to provide a clear picture of what the health risks to women are of different types of breast implant.”

“The recently convened Expert Group now needs to consider the problem of how to draw conclusions about implant performance in the absence of any national database. This gap in information was entirely predictable and relates to the problems associated with voluntary registration of implant procedures and of regulating the market in .”

Professor Kent says, however, that the issues of regulation are not just national, they are global.

“Regulating the global market in healthcare products is a difficult process not least because regulatory regimes vary across different parts of the world. Weaknesses in the European regulatory approach in relation to medical devices have previously been identified and reliance on 'notified bodies' to ensure products meet safety standards has been a concern for some years. Women may assume that they can trust regulators to act to protect their but enforcement of across international borders raises real problems for regulators and exposes consumers and patients to risks.”

In conclusion Professor Kent says the debate needs to focus on the ethical issues, as well as psychological and social issues, to ensure that lessons are learned from the current crisis.

Breast implant technology is discussed by Professor Kent in a forthcoming book edited by Professor Nichola Rumsey and Dr. Diana Harcourt from UWE's Center for Appearance Research, entitled, 'The Oxford Handbook of the Psychology of Appearance' published by Oxford University Press.

Explore further: New UK data 'shows higher risk of breast implant ruptures'

More information: Kent, J. (2003) Lay experts and the politics of breast implants. Public Understanding of Science, 12 (4). pp. 401-419. ISSN 0963-6625

Related Stories

New UK data 'shows higher risk of breast implant ruptures'

January 1, 2012
Britain's biggest cosmetic surgery chain has revealed that rupture rates on allegedly faulty French-made breast implants are seven times higher than previously thought, a report said Sunday.

UK demands data on breast implant ruptures

January 4, 2012
(AP) -- Britain's health secretary has demanded that private U.K. clinics supply data by the end of the week on how many French-made PIP breast implants have ruptured in Britain.

Britain reviews data on French breast implants

December 31, 2011
Britain's health minister said Saturday he has ordered an urgent review of the data used to assess the risks of breast implants made by French firm PIP, after receiving "conflicting" information.

Australia: No higher risk from French implants

January 5, 2012
(AP) -- Australian health officials said they have found no evidence that potentially faulty French-made breast implants are at an increased risk of rupture in Australian women.

Interpol seeks arrest of breast implant company founder

December 24, 2011
Interpol on Friday issued a "red notice" seeking the arrest of Frenchman Jean-Claude Mas, founder of the breast implant company at the centre of a widespread women's health scare.

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.